Achieving FDA and EMA Compliance in Temperature Monitoring

Freezer for temperature monitoring.
Document
Achieving FDA and EMA Compliance in Temperature Monitoring

Pharmaceuticals and biologics often require strict temperature control to stay safe and effective. Deviation from these conditions can cause degradation. Regulatory bodies like the FDA and EMA enforce strict guidelines to ensure product quality during manufacturing, storage, and transport.

Go to document
Many pharmaceuticals and biological products require specific temperature conditions during manufacturing, storage, and transport to ensure their quality and safety. Failure to maintain these conditions can lead to product degradation, making them less effective or even dangerous.
Key Considerations for Life Science Companies

To protect public health, regulatory authorities like the US Food and Drug Administration (FDA) and European Medicines Agency (EMA) have established strict guidelines to manage these products. To comply with these regulations, life science companies must adopt advanced temperature monitoring systems that can track and record conditions continuously and reliably.

This whitepaper explains the main requirements from both the FDA and EMA, the role of technology in maintaining compliance, and the best practices for setting up effective temperature monitoring systems.

You may also be interested in

A green icon of a hand holding a globe with leaves, representing sustainability.

Cooperation with Swedish Innovation Authority and University to Optimize Sustainability Procedures

Loggers with reusable components can decrease the carbon footprint by almost 90% compared to disposable. These important discoveries were made during a close collaboration between business, research, and authorities to prepare for more environmentally and socially sustainable business practices.
Read moreDownload Whitepaper
A notepad with a "Net Zero plan," representing sustainability in the pharma supply chain.

10 Steps to Navigating Sustainability in the Pharma Supply Chain

In the complex world of pharmaceuticals, sustainability is becoming a key part of business strategy. The push for a greener future is driven not only by government rules but also by the expectations of communities and customers. However, making the supply chain sustainable while balancing costs and maintaining high quality can be challenging. This requires careful planning and a commitment to long-term goals.
Read moreDownload Whitepaper
A doctor and patient in a clinical trial consultation.

How to Scale Up Your Clinical Trials

Pharmaceutical companies are under pressure to bring new drugs to market quickly. This urgency is driven by the needs of patients, requirements from authorities, and investors. Clinical trials are a crucial part of this process, but they can be delayed by manual processes.
Read moreDownload Whitepaper

You may also be interested in

TSS Sponsors the 27th Annual Clinical Trial Supply Europe 2026 in Barcelona

TSS is proud to sponsor the 27th Annual Clinical Trial Supply Europe, taking place 24–25 February 2026 in Barcelona, Spain. The event brings together clinical supply professionals, sponsors, CROs, and solution providers to discuss how to strengthen resilience, quality, and patient safety across the clinical trial supply chain.
Read more

Can You Rely on the Results from Your Clinical Trials?

The success of a clinical trial depends on the reliability of its data. Many investigational drugs are sensitive to temperature, and any temperature deviation can affect their quality and, in the worst case, patient safety. Automated and integrated temperature monitoring solutions help secure data quality, support compliance, and speed up the delivery of new medicines to patients.
Read more

Subscribe to our newsletter

Sign up for our newsletter to receive all the latest TSS news and insights in temperature management solutions.